Anti-YTHDF2 antibody [EPR20318] (Ab220163)

HGRG8, YTHDF2, YTH domain-containing family protein 2, DF2, CLL-associated antigen KW-14, High-glucose-regulated protein 8, Renal carcinoma antigen NY-REN-2

反应种属:Human, Mouse, Rat
抗原名称:YTHDF2
应用:WB, IP

用户验证的应用

推荐稀释比例

  • WB1/1000
  • IP1/30

详细信息

免疫原The exact immunogen used to generate this antibody is proprietary information.
宿主/亚型Rabbit / IgG
抗体类型Monoclonal
全称Anti-YTHDF2 antibody [EPR20318]
产品形式Liquid
储存缓冲液pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
储存条件运输条件: Conditional Ambient 推荐的短期储存时间: 1-2 weeks 推荐的短期储存条件: +4°C 推荐的长期储存条件: -20°C 储存信息: Avoid freeze / thaw cycle
纯化方式Affinity purification Protein A

背景信息

What is this antibody validated in? Anti-YTHDF2 antibody [EPR20318] (ab220163) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP) in Human, Mouse, Rat samples. What is the molecular weight of YTHDF2? Anti-YTHDF2 [EPR20318] (ab220163) specifically detects a band for YTHDF2 (UniProt: Q9Y5A9) at a molecular weight of 62kDa. Trusted by the scientific community Anti-YTHDF2 [EPR20318] (ab220163) was first used in a scientific publication in 2018 and has been cited over 50 times in peer-reviewed journals. Specificity confirmed The specificity of Anti-YTHDF2 antibody [EPR20318] (ab220163) has been confirmed by Western blot testing in YTHDF2 Knockout mESC cells. Other related products We have a range of other formats of antibody clone [EPR20318] also available for your convenience: ab220163, Carrier free - ab245129 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.

文献引用 (92)

BARD1-mediated stabilization of METTL14 promotes retinal neovascularization by m6A-modifying MXD1 mRNA on a YTHDF2-dependent manner.

BARD1介导的METTL14稳定化通过m6A修饰MXD1 mRNA,以YTHDF2依赖的方式促进视网膜新生血管形成

Liu Xianyang, Zeng Shuhao, Meng Jiayu, Zhou Qian, Cao Fan, Chu Baorui, Wu Chao, Wang Yakun, Feng Hui, Bi Xiaorui, Chen Xinyuan, Yang Wenxian, Tian Meng, Yang Hui, Hu Ke, Hou Shengping

Targeting YTHDF2 with pH-responsive siRNA nanoparticles suppresses MYC m6A modification and restores antitumor immunity in hepatocellular carcinoma

利用pH响应性siRNA纳米颗粒靶向YTHDF2可抑制MYC m6A修饰并恢复肝细胞癌的抗肿瘤免疫力。

Ziqi Guo,Qiuling Huang,Zhenzhen Cui,Cheng Yang,Liu Yang

Enriched environment inhibits GLT-1 ubiquitination by downregulating SMURF1 to attenuate ischemic brain injury induced excitotoxicity.

富集环境通过下调 SMURF1 来抑制 GLT-1 泛素化,从而减轻缺血性脑损伤引起的兴奋性毒性

Zhang Yi, Liu Wen, Huang Tao, Liu Lingling, Chen Xiuping

KCTD10 inhibits lung cancer metastasis and angiogenesis via ubiquitin-mediated β-catenin degradation.

KCTD10 通过泛素介导的β-catenin降解抑制肺癌转移和血管生成

Yin Zihao, Long Shengwen, Zhou Hao, Ouyang Mi, Wang Qinghao, He Jun, Su Rongyu, Li Zhiwei, Ding Xiaofeng, Xiang Shuanglin

Molecular mechanism of ZC3H13 -mediated ferroptosis in doxorubicin resistance of triple negative breast cancer

ZC3H13介导的铁死亡在三阴性乳腺癌阿霉素耐药中的分子机制

Li Huang, Lei Han, Shuai Liang, Guohui Han

The RNA-binding protein YTHDF3 affects gastric cancer cell migration and response to paclitaxel by regulating EZRIN.

RNA结合蛋白YTHDF3通过调节EZRIN影响胃癌细胞的迁移和对紫杉醇的反应

Mesquita Patrícia, Coelho Alexandre, Ribeiro Ana S, Póvoas Luís F C, de Oliveira Catarina, Leça Nelson, Silva Sara, Ferreira Diana, Pádua Diana, Coelho Ricardo, Jerónimo Carmen, Paredes Joana, Conde Carlos, Pereira Bruno, Almeida Raquel

ZHX2 inhibits diabetes-induced liver injury and ferroptosis by epigenetic silence of YTHDF2

ZHX2 通过表观遗传沉默 YTHDF2 来抑制糖尿病引起的肝损伤和铁死亡

Wei Meng, Linghua Li

METTL3-mediated m(6)A modification promotes intervertebral disc degeneration.

METTL3 介导的 m(6)A 修饰促进椎间盘退变

Yang Qinghua, Huang Feihong, Wang Congyang, Liang Xiao, Huang Longao, Xu Hongyuan, Liu Jianwei, Wei Qingjun, Jiang Hua

WTAP Accelerates Exhaustion of CD8(+) T Cells and Progression of Hepatocellular Carcinoma by Promoting m6A Modification and Translation of PD1 mRNA.

WTAP 通过促进 PD1 mRNA 的 m6A 修饰和翻译,加速 CD8(+) T 细胞的耗竭和肝细胞癌的进展

Li Rong, Li Shunle, Li Hua, Liu Bingli, Wang Zimu, Lei Huanqin, Li Yuting, Jia Lijuan, Li Junhui, Lu Hongwei, Xu Meng

YTHDF2 promotes the metastasis of oral squamous cell carcinoma through the JAK-STAT pathway.

YTHDF2 通过 JAK-STAT 通路促进口腔鳞状细胞癌的转移

Chen Zhezheng, Zhao Dan, Yuan Yamin, Zeng Lu, Luo Zhengzhou, Chen Junliang, Lan Xiaorong, He Yun, Liu Lin
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10